SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 93 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,182,000 | -21.4% | 2,189,700 | +28.9% | 1.48% | -15.5% |
| Q3 2021 | $12,957,000 | +11.6% | 1,698,107 | +41.7% | 1.75% | +7.0% |
| Q2 2021 | $11,608,000 | +31.8% | 1,197,976 | +12.5% | 1.64% | -4.5% |
| Q1 2021 | $8,807,000 | +30.3% | 1,064,933 | +75.6% | 1.71% | +69.9% |
| Q3 2020 | $6,760,000 | +1177.9% | 606,298 | +111.0% | 1.01% | +358.6% |
| Q1 2020 | $529,000 | +475.0% | 287,386 | +957.4% | 0.22% | +746.2% |
| Q4 2019 | $92,000 | – | 27,178 | -67.9% | 0.03% | – |
| Q4 2018 | $0 | -100.0% | 84,536 | +388.6% | 0.00% | -100.0% |
| Q2 2017 | $35,000 | -78.4% | 17,300 | -17.6% | 0.00% | -66.7% |
| Q3 2016 | $162,000 | -88.6% | 20,986 | -91.7% | 0.01% | -91.9% |
| Q2 2016 | $1,421,000 | -30.4% | 253,805 | -33.2% | 0.07% | -27.5% |
| Q1 2016 | $2,043,000 | -21.8% | 379,800 | +26.6% | 0.10% | -29.2% |
| Q4 2015 | $2,613,000 | +86.4% | 300,000 | +79.6% | 0.14% | +148.3% |
| Q3 2015 | $1,402,000 | -22.0% | 167,064 | -24.8% | 0.06% | -49.6% |
| Q4 2013 | $1,798,000 | – | 222,026 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |